Kronos Worldwide vs NLI
KRO and NL side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How KRO and NL compare
Kronos Worldwide is the larger company, worth 2.8 times as much as NLI ($954M against $346M).
Kronos Worldwide grew revenue faster over the last twelve months (8.7% versus 4.3% for NLI).
Kronos Worldwide keeps more of each dollar of sales as profit, with a net margin of −1.9% compared with −3.0% at NLI.
Both pay dividends: Kronos Worldwide yields 2.4% and NLI 5.5%.
NLI scores higher on the StockData Score (14 against 4 for Kronos Worldwide), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | KRO | NL |
|---|---|---|
| Size and price | ||
| Market cap | $954M | $346M |
| Share price | $8.29 | $7.07 |
| Change, 1 year | 71.3% | 25.1% |
| Change, 5 years | −40.4% | 11.2% |
| Beta (5Y) | 1.18 | 0.80 |
| Employees | 2,248 | 549 |
| StockData Score | ||
| Total score | 4 | 14 (better) |
| Valuation score | 0 | 4 (better) |
| Growth score | 1 | 1 |
| Performance score | 0 | 0 |
| Health score | 2 | 6 (better) |
| Dividend score | 1 | 3 (better) |
| Valuation | ||
| P/S | 0.5× (better) | 2.1× |
| P/B | 1.2× | 0.9× (better) |
| EV/EBITDA | 32.5× | 12.8× (better) |
| P/FCF | – | 36.0× |
| FCF yield | – | 2.8% |
| Fair value | $3.59 | $8.91 |
| Margin of safety | −131% | 20.6% (better) |
| Growth | ||
| Revenue growth (TTM) | 8.7% (better) | 4.3% |
| Revenue growth, 5Y average | 2.6% | 6.7% (better) |
| Net income growth (TTM) | – | −151% |
| EPS growth (TTM) | – | −150% |
| Profitability | ||
| Gross margin | 15.3% | 32.5% (better) |
| Operating margin | 2.2% | 9.8% (better) |
| Net margin | −1.9% (better) | −3.0% |
| FCF margin | – | 5.8% |
| Return on equity | −4.7% | −1.3% (better) |
| Return on invested capital | 2.6% | 4.8% (better) |
| Financial health | ||
| Debt / equity | 0.69 (better) | 0.00 |
| Net debt / EBITDA | 11.28 | – |
| Interest coverage | 0.8× | 370× (better) |
| Current ratio | 3.30 | 7.25 (better) |
| Altman Z-score | 2.05 | 3.71 (better) |
| Piotroski F-score | 4 | 4 |
| Dividends and buybacks | ||
| Dividend yield | 2.4% | 5.5% (better) |
| Years of dividend growth | 0 | 0 |
| Dividend growth, 5Y average | −22.6% | 28.9% (better) |
| Shareholder yield | 2.4% | 5.5% (better) |
| Ownership | ||
| Held by institutions | 16.0% | 11.3% |
| Held by insiders | 0.21% | 0.41% |
| Insider net buying, 12 months | $98.5K | – |
| Short interest, % of float | 0.94% | 0.19% |
Go deeper
- KRO stock overview
- KRO income statement
- KRO valuation and score
- NL stock overview
- NL income statement
- NL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.